Technology & Science
Jul. 1, 2010
Biotech Partners With Big Pharma
A Redwood City-based biotechnology company is striking deals with major pharmaceutical companies, giving its partners the option to exclusively license anti-cancer stem cell therapeutics.
Daily Journal Staff Writer
A Redwood City biotechnology company is striking deals with major pharmaceutical companies, giving its partners the option to exclusively license anti-cancer stem cell therapeutics.
The arrangement is unusual, said an attorney representing OncoMed Pharmaceuticals Inc., because it gives large pharmaceutical companies the choice to license any treatments developed while also preserving...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In